References
- Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43–66.
- Ghosh N, Matsui W. Cancer stem cells in multiple myeloma. Cancer Lett 2009;277:1–7.
- Billadeau D, Ahmann G, Greipp P, Van Ness B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med 1993;178:1023–1031.
- Dementyeva E, Nemec P, Kryukov F, et al. Centrosome amplification as a possible marker of mitotic disruptions and cellular carcinogenesis in multiple myeloma. Leuk Res 2010;34:1007–1011.
- Chng WJ, Fonseca R. Centrosomes and myeloma; aneuploidy and proliferation. Environ Mol Mutagen 2009;50:697–707.
- Chng WJ, Ahmann GJ, Henderson K, et al. Clinical implication of centrosome amplification in plasma cell neoplasm. Blood 2006;107:3669–3675.
- Ahmann GJ, Jalal SM, Juneau AL, et al. A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies. Cancer Genet Cytogenet 1998;101:7–11.
- Greslikova H, Zaoralova R, Filkova H, et al. Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation. Neoplasma 2010;57:111–117.
- Kawamura K, Izumi H, Ma Z, et al. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression. Cancer Res 2004;64:4800–4809.
- Rebacz B, Larsen TO, Clausen MH, et al. Identification ofgriseofulvin as an inhibitor of centrosomal clustering inaphenotype-based screen. Cancer Res 2007;67:6342–6350.
- Krämer A, Neben K, Ho AD. Centrosome replication, genomic instability and cancer. Leukemia 2002;16:767–775.